|
Alzheimer's disease
Citations 451-460 of 570 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
A visuospatial variant of mild cognitive impairment: Getting lost between aging and AD
- Mark Mapstone, Teresa M. Steffenella, and Charles J. Duffy
Neurology 2003; 60: 802-808.
[Abstract]
[Full text]
[PDF]
- ARTICLES
CSF Aß 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
- D. Strozyk, K. Blennow, L. R. White, and L. J. Launer
Neurology 2003; 60: 652-656.
[Abstract]
[Full text]
[PDF]
- MEDICAL HYPOTHESIS
Will caloric restriction and folate protect against AD and PD?
- Mark P. Mattson
Neurology 2003; 60: 690-695.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Impaired financial abilities in mild cognitive impairment: A direct assessment approach
- H.R. Griffith, K. Belue, A. Sicola, S. Krzywanski, E. Zamrini, L. Harrell, and D.C. Marson
Neurology 2003; 60: 449-457.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Atrophy rates of entorhinal cortex in AD and normal aging
- A. T. Du, N. Schuff, X. P. Zhu, W. J. Jagust, B. L. Miller, B. R. Reed, J. H. Kramer, D. Mungas, K. Yaffe, H. C. Chui, and M. W. Weiner
Neurology 2003; 60: 481-486.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Early onset familial Alzheimers disease: Mutation frequency in 31 families
- J.C. Janssen, J.A. Beck, T.A. Campbell, A. Dickinson, N.C. Fox, R.J. Harvey, H. Houlden, M.N. Rossor, and J. Collinge
Neurology 2003; 60: 235-239.
[Abstract]
[Full text]
[PDF]
- ARTICLES
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy
- Yoshio Tsuboi, Keith A. Josephs, Natalie Cookson, and Dennis W. Dickson
Neurology 2003; 60: 240-245.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Apolipoprotein E 4 allele, AD pathology, and the clinical expression of Alzheimers disease
- D.A. Bennett, R.S. Wilson, J.A. Schneider, D.A. Evans, N.T. Aggarwal, S.E. Arnold, E.J. Cochran, E. Berry-Kravis, and J.L. Bienias
Neurology 2003; 60: 246-252.
[Abstract]
[Full text]
[PDF]
- ARTICLES
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD
- C. R. Jack, Jr., M. Slomkowski, S. Gracon, T. M. Hoover, J. P. Felmlee, K. Stewart, Y. Xu, M. Shiung, P. C. OBrien, R. Cha, D. Knopman, and R. C. Petersen
Neurology 2003; 60: 253-260.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Telephone screening for amnestic mild cognitive impairment
- Christopher R. Lines, Kathleen A. McCarroll, Richard B. Lipton, and Gilbert A. Block
Neurology 2003; 60: 261-266.
[Abstract]
[Full text]
[PDF]
|
|